AMANDA CHAMBERS: Open Payments
NPI 1760071815 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 10 payments from 5 companies in 2025. Trend: 2023 $40 · 2024 $235 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 4 | $144 |
| ABBVIE INC. | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Novo Nordisk Inc | 1 | $21 |
Products named: EMBLAVEO, Filspari, Kerendia, JYNARQUE, Ozempic.
Industry payments across IN — which companies pay providers there.
